Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles. 2019

Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
a Department of Infectious Diseases, The Second Affiliated Hospital of Nanchang University, School of Pharmaceutical Science , Nanchang University , Nanchang PR China.

BACKGROUND To prepare sorafenib-loaded folate-decorated bovine serum nanoparticles (FA-SRF-BSANPs) and investigate their effect on the tumor targeting. METHODS The nanoparticles were characterized and evaluated by in vivo and in vitro experiments. RESULTS SRF-loaded BSA nanoparticles (SRF-BSANPs) was first prepared and modified with folic acid by chemical coupling to obtain FA-SRF-BSANPs. The average particle size, zeta potential, entrapment efficiency, and drug loading of the optimized FA-SRF-BSANPs were 158.00 nm, -16.27 mV, 77.25%, and 7.73%, respectively. The stability test showed that FA-SRF-BSANPs remained stable for more than 1 month at room temperature. The TEM analysis showed that the surface of FA-SRF-BSANPs was nearly spherical. XRD analysis showed that the drug existed in. the nanoparticles in an amorphous state. FA-SRF-BSANPs can promote the intracellular uptake of hepatoma cells (SMMC-7721) with the strongest inhibitory effect compared with SRF-BSANPs and sorafenib solution. Furthermore, the tumor targeting of FA-SRF-BSANPs (Ctumor/Cblood, 0.666 ± 0.053) was significantly higher than those of SRF-BSANPs (Ctumor/Cblood, 0.560 ± 0.083) and sorafenib-solution (Ctumor/Cblood, 0.410 ± 0.038) in nude mice with liver cancer. CONCLUSIONS FA-modified albumin nanoparticles are good carriers for delivering SRF to the tumor tissue, which can improve the therapeutic effect and reduce the side effects of the drug.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005492 Folic Acid A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. Pteroylglutamic Acid,Vitamin M,Folacin,Folate,Folic Acid, (D)-Isomer,Folic Acid, (DL)-Isomer,Folic Acid, Calcium Salt (1:1),Folic Acid, Monopotassium Salt,Folic Acid, Monosodium Salt,Folic Acid, Potassium Salt,Folic Acid, Sodium Salt,Folvite,Vitamin B9,B9, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077157 Sorafenib A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy. 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate,BAY 43-9006,BAY 545-9085,BAY-545-9085,BAY-673472,Nexavar,Sorafenib N-Oxide,Sorafenib Tosylate,BAY 43 9006,BAY 439006,BAY 545 9085,BAY 5459085,BAY 673472,BAY5459085,Sorafenib N Oxide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
December 2014, Journal of materials chemistry. B,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
September 2010, International journal of nanomedicine,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
October 2014, Journal of nanobiotechnology,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
March 2015, Acta biomaterialia,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
February 2015, Drug delivery,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
April 2023, Animal biotechnology,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
January 2016, Chemical biology & drug design,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
March 2015, Molecular pharmaceutics,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
May 2013, Journal of biomedical materials research. Part A,
Haipeng Wang, and Shuilin Sun, and Yu Zhang, and Jiayi Wang, and Shouhua Zhang, and Xuebing Yao, and Ling Chen, and Zhen Gao, and Baogang Xie
June 2011, Acta pharmaceutica (Zagreb, Croatia),
Copied contents to your clipboard!